Rethinking tuberculosis: Microbiological and immunological crossroads in the post-pandemic era

Read full text Summarise with VIRAT
Authors: Mulavagili Vijayasimha, Rajesh Prasad Jayaswal
Cited by: 0
References: 1

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Tuberculosis (TB) remains a major global health concern, further complicated by disruptions in surveillance and management during the COVID-19 pandemic. Emerging evidence positions TB not only as an infectious disease but also as an immune-mediated condition, highlighting the role of host–pathogen interactions in disease persistence. Recent advances in molecular diagnostics, such as metagenomic sequencing, AI-assisted microscopy, and CRISPR-based assays, are transforming early detection and personalized care. At the same time, novel drug regimens for multidrug-resistant TB offer new hope. Integrating host-directed therapies with precision microbiology provides a promising framework for TB control in the post-pandemic era.

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Infectious Diseases and Tuberculosis Diagnosis and treatment of tuberculosis

Publication details

Journal / source
Revista Alergia México
Volume
73
Issue
1
Pages
109–110
Publication date
31 March 2026
Language
EN